Would that be the top pick of 2020 ? Exelixis shows strong balance sheet plus the growth potential from further expansion.
Stock Mover
- Exelixis Further Expands Prostate Cancer Cohort in Phase 1b
- Exelixis to Present at the 38th Annual J.P. Morgan Healthcare Conference on January 14, 2020
What do you guys think ?